Article Information
History
- January 27, 2023.
Article Versions
- Version 1 (January 27, 2023 - 08:12).
- You are currently viewing Version 2 of this article (January 27, 2023 - 14:36).
- Version 3 (June 28, 2023 - 08:39).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Theo Sanderson1,✉,
- Ryan Hisner2,
- I’ah Donovan-Banfield3,4,
- Thomas Peacock5 and
- Christopher Ruis6,7,8,✉
- 1Francis Crick Institute, London, UK
- 2Independent researcher, USA
- 3Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
- 4NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK
- 5Department of Infectious Disease, Imperial College London, London, UK
- 6Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK
- 7Department of Veterinary Medicine, University of Cambridge, Cambridge, UK
- 8Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK
- ↵✉Correspondence: theo.sanderson{at}crick.ac.uk cr628{at}cam.ac.uk
Posted January 27, 2023.
Identification of a molnupiravir-associated mutational signature in SARS-CoV-2 sequencing databases
